Tag: Small Pharma - Page 5 - Psychedelic Alpha

Read more about the article Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder

Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder

Post published:November 15, 2021
Post category:Press Release

Read more about the article Small Pharma Reports Second Quarter Highlights

Small Pharma Reports Second Quarter Highlights

Post published:November 1, 2021
Post category:Press Release

Read more about the article European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the Treatment of Depressive Disorders

European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the Treatment of Depressive Disorders

Post published:October 25, 2021
Post category:Press Release

Read more about the article Small Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy for Major Depressive Disorder

Small Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy for Major Depressive Disorder

Post published:October 21, 2021
Post category:Press Release

Read more about the article First Patient Dosed in Phase IIa DMT-Assisted Therapy Clinical Trial

First Patient Dosed in Phase IIa DMT-Assisted Therapy Clinical Trial

Post published:October 19, 2021
Post category:Press Release

Read more about the article Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy

Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy

Post published:September 21, 2021
Post category:Press Release

Read more about the article Small Pharma Announces Engagement of Investor Relations Provider

Small Pharma Announces Engagement of Investor Relations Provider

Post published:September 15, 2021
Post category:Press Release

Read more about the article Small Pharma Announces Appointment of Lyne Fortin as Chair of the Board

Small Pharma Announces Appointment of Lyne Fortin as Chair of the Board

Post published:August 27, 2021
Post category:Press Release

Read more about the article Small Pharma Reports First Fiscal Quarter 2021 Highlights

Small Pharma Reports First Fiscal Quarter 2021 Highlights

Post published:July 30, 2021
Post category:Press Release

Read more about the article Small Pharma Establishes Psychedelic-assisted Therapy Training Program

Small Pharma Establishes Psychedelic-assisted Therapy Training Program

Post published:July 21, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.